Physician profile
Joseph V Calderone
NPI 1083869457
$450.81
in general payments reported to CMS, 2019-2025
8 companies · $72.97 in 2025
The $72.97 reported for 2025 was more than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2022: $50.50 · 2023: $13.46 · 2024: $98.14 · 2025: $72.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $101 · Education: $83.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $101.39 |
| Education | $83.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $200.00 | 2019 | |
| Envista Holdings Corporation | $83.18 | 2024 | Optibond All-In-One |
| Zimvie INC. | $50.00 | 2025 | |
| Biohorizons Implant Systems INC. | $38.24 | 2022-2025 | Biohorizons Dental Implants |
| Voco America INC. | $28.42 | 2023-2024 | Futurabond U, Admira Fusion X-Tra, Grandio So Heavy Flow |
| Orapharma, A Division of Bausch Health US, LLC | $19.28 | 2022 | |
| Align Technology, INC. | $15.95 | 2022 | |
| Ultradent Products INC | $15.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Calderone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.